Pontifax Venture Capital
Pontifax Venture Capital is a healthcare-dedicated venture capital firm founded in 2004, managing $1.2 billion in assets. The firm focuses on transformative, cutting-edge life sciences technologies across all development stages. Pontifax's portfolio includes approximately 100 companies that develop breakthrough solutions to address substantial unmet needs in the healthcare sector. The firm is deeply involved in its portfolio management, taking a hands-on approach to nurture start-ups to maturity.
Pontifax Venture Capital
What We Do
Scouting out disruptive ideas in research centers and building exceptional companies.
Providing hands-on guidance, networking, and experience to maximize the potential for success.
Investing in clinical-stage companies, offering strategic direction, capital markets, and M&A expertise.
Industry Focus
Portfolio
Developing highly differentiated antibody-drug conjugates (ADCs) for underserved cancers.
#BioPharma
Developing antibody therapies that induce regeneration of damaged tissues.
#BioPharma
Developing oral enzyme therapeutics for rare and severe metabolic disorders affecting the kidney.
#BioPharma
Focused on developing innovative therapies to treat and cure viral diseases.
#BioPharma
Engaged in the research and development of targeted therapeutics for cancers and rare diseases.
#BioPharma
Developing an image-based functional flow reserve (FFR) measurement during coronary catheterization.
#Medical Devices
Key People
CEO
Managing Partner
Director
Director
Investment Committee Member
Principal